论文信息 - Immune-Modi fi ed Response Evaluation Criteria In Solid Tumors ( imRECIST ) : Re fi ning Guidelines to Assess the Clinical Bene fi t of Cancer Immunotherapy - 字舞流文

Immune-Modi fi ed Response Evaluation Criteria In Solid Tumors ( imRECIST ) : Re fi ning Guidelines to Assess the Clinical Bene fi t of Cancer Immunotherapy

J. Wolchok | T. Powles | F. Hodi | J. Tabernero | J. Soria | M. Nishino | G. Fine | M. Ballinger | A. Hoos | U. Beyer | Daniel S. Chen | Christine McKenna | David C. Smith | I. Rhee | B. Lyons | Nathan Winslow